Impact of time to appropriate therapy on mortality in patients with vancomycin intermediate staphylococcus aureus infection.

CONCLUSIONS: Our results suggest that empiric vancomycin use in patients with VISA infections does not result in excess mortality. Future studies should 1) include larger numbers of patients with VISA infections to confirm these findings and 2) determine the optimal antibiotic therapy for critically ill patients with MRSA and VISA infections. PMID: 27401565 [PubMed - as supplied by publisher]
Source: Antimicrobial Agents and Chemotherapy - Category: Microbiology Authors: Tags: Antimicrob Agents Chemother Source Type: research